Endeavors adopted by participants are such as acquisition of Enzymatics by Qiagen acquired solutions in order to enhance the product portfolio with respect to reagents needed in preparatory steps.ģ Next Generation Sequencing Market Variables, Trends & Scopeģ.1.1.1 Exponentially decreasing costs for genetic sequencingģ.1.1.2 Development of companion diagnostics and personalized medicineģ.1.1.3 Rise in competition amongst prominent market entitiesģ.1.1.4 Rising clinical opportunity for NGS technologyģ.1.1.5 Introduction of technological advancements in cloud computing and data integrationģ.1.1.6 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancerģ.1.2.1 Lack of computational efficiency for data managementģ.1.2.2 Non-value based NGS reimbursement policy and regulation statusģ.1.2.3 Challenges associated with NGS implementationģ.2 Penetration & Growth Prospect Mapping for Applications, 2015ģ.3 Penetration & Growth Prospect Mapping for Prominent Industry Players, 2015ģ.4 Next Generation Sequencing Platform Positioningģ.4.1 Major Sequencing Platforms Compared - Applicationsģ.4.2 Major Sequencing Platforms Compared - Specificationsģ.5 Next Generation Sequencing Platform Penetration Mapping, 2015ģ.6 Next Generation Sequencing Company Market Share Analysis, 2015ģ.7 Next Generation Sequencing Reimbursement Environmentģ.7.1 Gap fill approach for reimbursement of NGS testsģ.7.2.1 Payer perspectives for developing coverage policy for Next Generation Tumor Sequencing Panels (NGTS)ģ.7.3 Role of diagnostic laboratories and pathology centresģ.8 Next Generation Sequencing Regulatory Environmentģ.9 Next Generation Sequencing - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)Ĥ Next Generation Sequencing Market Application Estimates & Trend AnalysisĤ.1 Next Generation Sequencing Market: Application Movement AnalysisĤ.6 Metagenomics, Epidemiology & Drug Developmentĥ Next Generation Sequencing Market Technology Estimates & Trend Analysisĥ.1 Next Generation Sequencing Market: Technology Movement Analysisĥ.4.2 DNA based targeted sequencing & resequencingĥ.4.3 RNA based targeted sequencing & resequencingĦ Next Generation Sequencing Market Workflow Estimates & Trend AnalysisĦ.1 Next Generation Sequencing Market: Workflow Movement AnalysisĦ.2.3 NGS semi-automated library preparationħ Next Generation Sequencing Market End-use Estimates & Trend Analysisħ.Prior to the mid-1970s, researchers knew what DNA looked like, but the “message being expressed” wasn’t clear.Key players operating in the NGS market include Illumina Inc., Agilent Technologies, BGI, Pacific Biosciences, Qiagen, Roche, Thermo Fischer Scientific, and Oxford Nanopore Technologies Ltd.Asia Pacific is estimated to witness the fastest growth over the forecast period owing to expected routing of a considerable portion of whole genome sequencing requirements herein.
Higher adoption of this technology and platforms in university projects is expected to support the estimated share.Academic usage of NGS accounted for the largest share with respect to market revenue by end uses and is anticipated to maintain its dominance.Targeted resequencing dominated the market owing to its associated benefits such as implementation of the technique such as lower turnaround time and more manageable data sets.Oncology accounted for the dominant share owing to phase-resolved and unambiguous results obtained by using single assay systems, and analysis program.Moreover, improved understanding of the genetic markers of virulence and resistance provided by next generation sequencing is expected to drive demand of the technology in infectious disease diagnosis.įurther Key Findings from the Report suggest: Commercial payers are also engaged in reviewing the existing and novel tests in order to establish appropriate medical necessity criteria for their clinical and medical policies. Increasing coverage of NGS is expected to drive use of precision medicine in oncology from research based setting to clinical cancer setting. The global next generation sequencing market is anticipated to reach USD 21.4 billion by 2025 Research and Markets has announced the addition of the "Next Generation Sequencing (NGS) Market Size & Forecast By Application (Oncology, Reproductive Health), By Technology (Targeted Sequencing), By Workflow (Data Analysis), By end-use (Academic & Clinical Research), And Trend Analysis, 2014 - 2025" report to their offering.
0 kommentar(er)
